InvestorsHub Logo
Followers 13
Posts 559
Boards Moderated 0
Alias Born 12/31/2012

Re: None

Friday, 10/14/2016 5:46:02 PM

Friday, October 14, 2016 5:46:02 PM

Post# of 3707
"approximately 85% of the patients completing trials 301 and 302 are continuing in the open label safety study..." PTN CEO Carl Spana Q3 2016 Earnings CC page 2. So approximately 680 patients elected to move to the P3 open-label trial from the P2b trial. That tells me that 85% of the women were confirming that Brem works for them... Spin the info how ever one likes but to me it's Very Bullish for PTN.

GLTL
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent PTN News